To successfully implement the expanded research scope of the Human Retroviruses andOther Emerging Pathogens Activity and to achieve the long-term goal of establishing an internationally rcognized center of excellence in geographic medicine and emerging infectious diseases at the University of Hawaii infrastructural support is required for alterations and renovations. Specifically, funds are needed for two BLS--3 containment suites for the safe handling of virus-infected tissues, such as tissues from hantavirus-infected wild rodents, and of tissues and biological fluids from patients with fatal or life-threatening diseases of suspected infectious origin. Although the current laboratory space of the RRL is rated at BSL-2/3, this space is dedicated to research on HIV-1 and other human retroviruses. Additional laboratory space is available to the RRL on a separate floor of the Atherton Building of Leahi Hospital. Renovations of this space would permit the physical separation of HIV-1 and other retroviruses from infectious agents requiring a high level of containment. Drs. Yanagihara and Nerurkar have extensive experience in working under BSL-3 containment. The availability of these BSL-3 suites will significantly increase the breath and scope, as well as sophistication, of studies conducted by the RRL and lead to heightened research productivity and independent-funding competitiveness. Moreover, the in-houseexpertise will allow the development and implementation of collaborative projects requiring BSL-3 containment throughout the local research community. The investigator will: 1. Elucidate the worldwide epizootiology of hantaviruses harbored by arvicolid and cricetid rodents and by insectivores and carnivors. 2. Clarify the epidemiology and disease-causing potential of hantaviruses harbored by arvicolid and cricetid rodents and by insectivores and carnivores.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Priemer, David S; Wang, Mingsheng; Zhang, Shaobo et al. (2018) Small-cell Carcinomas of the Urinary Bladder and Prostate: TERT Promoter Mutation Status Differentiates Sites of Malignancy and Provides Evidence of Common Clonality Between Small-cell Carcinoma of the Urinary Bladder and Urothelial Carcinoma. Eur Urol Focus 4:880-888
Marciel, Michael P; Rose, Aaron H; Martinez, Verena et al. (2018) Calpain-2 inhibitor treatment preferentially reduces tumor progression for human colon cancer cells expressing highest levels of this enzyme. Cancer Med 7:175-183
Marciel, Michael P; Khadka, Vedbar S; Deng, Youpeng et al. (2018) Selenoprotein K deficiency inhibits melanoma by reducing calcium flux required for tumor growth and metastasis. Oncotarget 9:13407-13422
Pomozi, Viola; Brampton, Christopher; Szeri, Flóra et al. (2017) Functional Rescue of ABCC6 Deficiency by 4-Phenylbutyrate Therapy Reduces Dystrophic Calcification in Abcc6-/- Mice. J Invest Dermatol 137:595-602
Norton, Robert L; Fredericks, Gregory J; Huang, Zhi et al. (2017) Selenoprotein K regulation of palmitoylation and calpain cleavage of ASAP2 is required for efficient Fc?R-mediated phagocytosis. J Leukoc Biol 101:439-448
Baumer, Yvonne; McCurdy, Sara; Weatherby, Tina M et al. (2017) Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis. Nat Commun 8:1129
Wilcox, Christie L; Headlam, Jasmine L; Doyle, Thomas K et al. (2017) Assessing the Efficacy of First-Aid Measures in Physalia sp. Envenomation, Using Solution- and Blood Agarose-Based Models. Toxins (Basel) 9:
Yanagihara, Angel Anne; Wilcox, Christie L (2017) Cubozoan Sting-Site Seawater Rinse, Scraping, and Ice Can Increase Venom Load: Upending Current First Aid Recommendations. Toxins (Basel) 9:
Chang, Linda; Løhaugen, Gro C; Andres, Tamara et al. (2017) Adaptive working memory training improved brain function in human immunodeficiency virus-seropositive patients. Ann Neurol 81:17-34
Doyle, Thomas K; Headlam, Jasmine L; Wilcox, Christie L et al. (2017) Evaluation of Cyanea capillata Sting Management Protocols Using Ex Vivo and In Vitro Envenomation Models. Toxins (Basel) 9:

Showing the most recent 10 out of 347 publications